Providers assess response through monthly weight measurements, metabolic marker tracking, and patient-reported appetite and energy changes
Results may vary per individual.
doi: 10.1186/1741-7015-7-62
(2024) analyzed thousands of online discussions about GLP-1 agonists and found that some individuals experienced a decline in sex drive
Keywords: Glucagon-like peptide-1 receptor agonists, heart failure with preserved ejection fraction, 6-minute walk distance, major adverse cardiovascular events, type 2 diabetes, obesity The landscape of heart failure (HF) management is evolving alongside a deeper understanding of how metabolic dysfunction drives cardiac pathology and the progression of HF, particularly in phenotypes like HF with preserved ejection fraction (HFpEF) associated with obesity
Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study